Aptevo Therapeutics Cash and Cash Equivalents 2011-2026 | APVO

Annual Cash and Cash Equivalents Aptevo Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
21.6 M	8.71 M	16.9 M	22.6 M	45 M	40 M	12.4 M	30.6 M	7.1 M	9.68 M	4.64 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
45 M	4.64 M	19.9 M

Quarterly Cash and Cash Equivalents Aptevo Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
21.1 M	9.41 M	2.14 M	8.71 M	7.75 M	8.07 M	10.2 M	16.9 M	19.1 M	21 M	25.3 M	22.6 M	22.2 M	29.4 M	35 M	45 M	52.1 M	60.4 M	57.5 M	40 M	40 M	40 M	40 M	12.4 M	12.4 M	12.4 M	12.4 M	30.6 M	30.6 M	30.6 M	30.6 M	7.1 M	7.1 M	7.1 M	7.1 M	9.68 M	9.68 M	9.68 M	9.68 M	4.64 M	4.64 M	4.64 M	-	3.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
60.4 M	2.14 M	20.7 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Amphastar Pharmaceuticals AMPH	170 M	$ 21.94	2.48 %	$ 1.03 B	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	3.5 M	$ 0.9	0.49 %	$ 6.62 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	320 M	$ 22.66	3.19 %	$ 3.76 B	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	29 K	-	-2.5 %	$ 5.88 M	USA
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA
BioNTech SE BNTX	7.68 B	$ 102.75	-2.57 %	$ 27.2 B	Germany
Avenue Therapeutics ATXI	2.86 M	-	-52.27 %	$ 4.45 M	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	121 M	$ 4.14	1.35 %	$ 443 M	USA
Arcutis Biotherapeutics ARQT	42.9 M	$ 23.58	1.38 %	$ 3 B	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Autolus Therapeutics plc AUTL	104 M	$ 1.44	-0.35 %	$ 383 M	Britain
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 2.92	-0.45 %	$ 4.81 M	Israel
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
ContraFect Corporation CFRX	8.91 M	-	-5.16 %	$ 5.39 M	USA
Cardiff Oncology CRDF	17.5 M	$ 1.72	-	$ 115 M	USA
BioXcel Therapeutics BTAI	28.4 M	$ 1.1	3.77 %	$ 13.4 M	USA
Cabaletta Bio CABA	83 M	$ 2.99	1.19 %	$ 300 M	USA
Cara Therapeutics CARA	20.7 M	-	-3.03 %	$ 260 M	USA
Allena Pharmaceuticals ALNA	30 M	-	3.16 %	$ 1.9 M	USA
CASI Pharmaceuticals CASI	38.7 M	-	-	$ 35.4 M	USA
CymaBay Therapeutics CBAY	207 M	-	-	$ 3.45 B	USA